A question likely to be on the minds of a lot of investors right now is how economic uncertainty caused by the Covid pandemic will continue to affect mid-cap shares like Pharmagest Interactive Sa (EPA:PHA). Shares in Pharmagest Intera...
|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2016||2017||2018||2019||2020||2021E||2022E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for PHA
Shares in Pharmagest Interactive Sa (EPA:PHA) are currently trading at 79.5 but a key question for investors is how the economic uncertainty caused by Covid-19 will affect the price in the months to come. The answer comes down to judgi...
Quality and momentum are highly prized among investors looking for reliable investment ideas. That's because good quality stocks tend to be resilient, cash-generating businesses that can compound investment returns over time. And those...
The Pharmagest Interactive Sa (EPA:PHA) share price is currently trading at 82.1. But given the volatile market conditions and uncertain economic outlook, the question now is what the future holds for it. To try and predict where the P...
The Pharmagest Interactive Sa (EPA:PHA) share price is currently trading at 65.6. But to try and predict what the price will look like in the next 12 months and beyond, it's worth knowing its strengths and potential weaknesses. The goo...
Pharmagest Interactive SA is a France-based company that develops and integrates management software packages for drugstores. The Company is engaged in the computerization of pharmaceutical dispensaries. Its flagship product is Integrated Portal Management Software, which provides pharmacists with permanent and immediate access to a range of online services and is used for the distribution of information and promotions for pharmaceutical suppliers and for pharmaceutical laboratories. In addition, the Company is engaged in the provision of maintenance services, technologies to manage medication compliance, as well as e-business solutions. It operates through Noviatek, Sailendra, Multimeds, British Caremeds and Axigate, among others.
- Thierry Chapusot CHM (59)
- Dominique Pautrat CEO (54)
- Thierry Ponnelle DCE (58)
- Denis Supplisson DCE (49)
- Jean-Yves Samson FID
- Gregoire de Rotalier DMD (50)
- Rodolphe Zimmer DHR
- Daniel Antoine DRC (66)
- Francois Jacquel DRC (60)
- Emilie Lecomte DRC (40)
- Anne Lhote DRC (50)
- Hugues Moreaux DRC (65)
- Celine Gris IND (41)
- Sophie Mayeux IND (61)
Latest News for PHA
Upcoming Events for PHA
As of Today at 06:36 UTC, shares in Pharmagest Interactive SA are trading at €85.70. This share price information is delayed by 15 minutes.
Shares in Pharmagest Interactive SA last closed at €85.70 and the price had moved by -11.92% over the past 365 days. In terms of relative price strength the Pharmagest Interactive SA share price has underperformed the FTSE Global All Cap Index by -28.33% over the past year.
The overall consensus recommendation for Pharmagest Interactive SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Pharmagest Interactive SA dividend yield is 1.11% based on the trailing twelve month period.
Last year, Pharmagest Interactive SA paid a total dividend of €0.95, and it currently has a trailing dividend yield of 1.11%. We do not have any data on when Pharmagest Interactive SA is to next pay dividends.
We do not have data on when Pharmagest Interactive SA is to next pay dividends. The historic dividend yield on Pharmagest Interactive SA shares is currently 1.11%.
To buy shares in Pharmagest Interactive SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €85.70, shares in Pharmagest Interactive SA had a market capitalisation of €1.29bn.
Here are the trading details for Pharmagest Interactive SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: PHA
Based on an overall assessment of its quality, value and momentum Pharmagest Interactive SA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Pharmagest Interactive SA is €132.50. That is 54.61% above the last closing price of €85.70.
Analysts covering Pharmagest Interactive SA currently have a consensus Earnings Per Share (EPS) forecast of €2.60 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pharmagest Interactive SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -12.8%.
As of the last closing price of €85.70, shares in Pharmagest Interactive SA were trading -9.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Pharmagest Interactive SA PE ratio based on its reported earnings over the past 12 months is 29.48. The shares last closed at €85.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Pharmagest Interactive SA's management team is headed by:
- Thierry Chapusot - CHM
- Dominique Pautrat - CEO
- Thierry Ponnelle - DCE
- Denis Supplisson - DCE
- Jean-Yves Samson - FID
- Gregoire de Rotalier - DMD
- Rodolphe Zimmer - DHR
- Daniel Antoine - DRC
- Francois Jacquel - DRC
- Emilie Lecomte - DRC
- Anne Lhote - DRC
- Hugues Moreaux - DRC
- Celine Gris - IND
- Sophie Mayeux - IND